Exela Pharma Sciences, LLC.   Report issue

For profit Phase 3
Founded: Lenoir NC United States (2005)

Organization Overview

First Clinical Trial
2014
NCT02216071
First Marketed Drug
2005
verapamil (calan)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

EXELA HOLDINGS | EXELA PHARMA | EXELA PHARMA SCIENCE | Exela Pharma Sciences, LLC. | EXELA PHARMA SCS LLC